z-logo
open-access-imgOpen Access
FOXA1 expression in Iraqi women with ER+ breast cancer
Author(s) -
Iman Al-Bedairy,
Mais Shamsa,
Safaa aldeen Salim,
Mohammed Salih Mahdi,
Karam Dawood,
Abdul Hussein Al Faisal
Publication year - 2021
Publication title -
baghdad journal of biochemistry and applied biological sciences
Language(s) - English
Resource type - Journals
eISSN - 2706-9915
pISSN - 2706-9907
DOI - 10.47419/bjbabs.v2i02.43
Subject(s) - foxa1 , breast cancer , immunohistochemistry , estrogen receptor , biomarker , oncology , cancer research , medicine , cancer , biology , genetics
Background: Breast cancer (BC) is a heterogeneous disease that can be classified into many subtypes according to histopathological and molecular characteristics. Forkhead box protein A1 (FOXA1) is a transcriptional pioneer factor that opens chromatin allowing estrogen receptor (α-ER) access to its genomic targets. FOXA1 expression is related to luminal BC with a good prognosis.Objectives: The present study is sought to determine the FOXA1 expression in Iraqi women with ER+ BC.Methods: Forty-eight fresh malignant breast tissues were analyzed by immunohistochemistry assay to choose ER+ samples, and then by RT-qPCR to evaluate FOXA1 gene expression.Results: The ER-positive samples were (72.91%) of the total samples, and the molecular subtype of luminal A was the most common with a percentage of 56.25%. It was also noted that the high expression of the FOXA1 gene is highly significant (p<0.05) in Iraqi women with BC when compared with healthy controls.Conclusions: Highly significant FOXA1 expression was found in Iraqi women with BC makes it eligible to be a good predictor or a biomarker for BC.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom